Planning Executing Small-Scale Model Qualification For Upstream Downstream Biopharma Processing
Planning & Executing Small-Scale Model Qualification For Upstream & Downstream Biopharma Processing By Joschka Johannes Buyel (Bayer AG), Klaus Kaiser (Bayer AG), Kiran Andra (Alexion), Robert G. Luo (GlaxoSmithKline R&D), Alexis Henry (Biogen), Caroline Leveder (Sanofi R&D), Mark Richards (Eisai Inc.), Trish Connolly (BioPhorum Development Group) This article is the second in a three-part series that summarizes the discussions and exchanges of a BioPhorum Development Group workstream on small-scale model justification. Their purpose is to provide reference documents for bioprocess profession...
Source: pharmaceuticalonline.com